Semler Scientific Inc Market Cap ($348.27 Million)
Market Cap & Net Worth: Semler Scientific Inc (SMLR)
Semler Scientific Inc market cap. Semler Scientific Inc (NASDAQ:SMLR) has a market capitalization of $348.27 Million ($348.27 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13782 globally and #3333 in its home market, demonstrating a 1734.95% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Semler Scientific Inc's stock price $355.43 by its total outstanding shares 15142195 (15.14 Million). Also see Semler Scientific Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Semler Scientific Inc Market Cap History (2015–2026)
Semler Scientific Inc market cap history from 2015 to 2026. Data shows growth from $38.76 Million to $5.38 Billion (58.44% CAGR). Check Semler Scientific Inc stock quote for real-time trading data and today's change.
Index Memberships
Semler Scientific Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.01% | #369 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #1352 of 3165 |
Weight: Semler Scientific Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Semler Scientific Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Semler Scientific Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore SMLR shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
14.53x
Semler Scientific Inc's market cap is 14.53 times its annual revenue
Latest Price to Earnings (P/E) Ratio
19.99x
Semler Scientific Inc's market cap is 19.99 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $38.76 Million | $7.00 Million | -$8.50 Million | 5.54x | N/A |
| 2016 | $21.96 Million | $7.43 Million | -$2.55 Million | 2.95x | N/A |
| 2017 | $121.14 Million | $12.45 Million | -$1.51 Million | 9.73x | N/A |
| 2018 | $520.89 Million | $21.49 Million | $5.01 Million | 24.24x | 103.89x |
| 2019 | $726.83 Million | $32.77 Million | $15.08 Million | 22.18x | 48.19x |
| 2020 | $1.42 Billion | $38.60 Million | $14.01 Million | 36.87x | 101.62x |
| 2021 | $1.39 Billion | $53.03 Million | $17.22 Million | 26.17x | 80.58x |
| 2022 | $499.69 Million | $56.69 Million | $14.32 Million | 8.82x | 34.88x |
| 2023 | $670.65 Million | $68.18 Million | $20.58 Million | 9.84x | 32.58x |
| 2024 | $817.68 Million | $56.29 Million | $40.90 Million | 14.53x | 19.99x |
Competitor Companies of SMLR by Market Capitalization
Companies near Semler Scientific Inc in the global market cap rankings as of November 4, 2026. Also see balance sheet size of Semler Scientific Inc for a full breakdown of the balance sheet.
Key companies related to Semler Scientific Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Semler Scientific Inc (2015–2026)
Market capitalization of Semler Scientific Inc from 2015 to today. Between 2015 and today, Semler Scientific Inc's market cap moved from $38.76 Million to $ 5.38 Billion, with a yearly change of 58.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $5.38 Billion | +2224.59% |
| 2025 | $231.52 Million | -71.69% |
| 2024 | $817.68 Million | +21.92% |
| 2023 | $670.65 Million | +34.21% |
| 2022 | $499.69 Million | -63.99% |
| 2021 | $1.39 Billion | -2.50% |
| 2020 | $1.42 Billion | +95.83% |
| 2019 | $726.83 Million | +39.53% |
| 2018 | $520.89 Million | +330.00% |
| 2017 | $121.14 Million | +451.72% |
| 2016 | $21.96 Million | -43.36% |
| 2015 | $38.76 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Semler Scientific Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $348.27 Million USD |
| MoneyControl | $348.27 Million USD |
| MarketWatch | $348.27 Million USD |
| marketcap.company | $348.27 Million USD |
| Reuters | $348.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Semler Scientific Inc
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardi… Read more